Summary by Moomoo AI
John J. Boniface, Chief Scientific Officer of Sera Prognostics, completed a sale of 22,163 shares of the company's common stock on March 25, 2024. The transaction was executed at a price of $9.10 per share, resulting in a total sale value of $201,683.30. Following the sale, Boniface's direct holdings in Sera Prognostics amount to 164,962 shares. The sale took place in an open market or private sale, according to the transaction details provided.